Tianhong Li, Ph.D. - Publications

Affiliations: 
2003 Northwestern University, Evanston, IL 

55/81 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Li H, Xu Y, Wan B, Song Y, Zhan P, Hu Y, Zhang Q, Zhang F, Liu H, Li T, Sugimura H, Cappuzzo F, Lin D, Lv T. The clinicopathological and prognostic significance of PD-L1 expression assessed by immunohistochemistry in lung cancer: a meta-analysis of 50 studies with 11,383 patients. Translational Lung Cancer Research. 8: 429-449. PMID 31555517 DOI: 10.21037/tlcr.2019.08.04  0.44
2019 Gregg JP, Li T, Yoneda KY. Molecular testing strategies in non-small cell lung cancer: optimizing the diagnostic journey. Translational Lung Cancer Research. 8: 286-301. PMID 31367542 DOI: 10.21037/tlcr.2019.04.14  0.36
2019 Xiao W, Ma W, Wei S, Li Q, Liu R, Carney RP, Yang K, Lee J, Nyugen A, Yoneda KY, Lam KS, Li T. Correction to: High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancer. Journal of Hematology & Oncology. 12: 83. PMID 31349855 DOI: 10.1186/s13045-019-0764-z  0.84
2019 Xiao W, Ma W, Wei S, Li Q, Liu R, Carney RP, Yang K, Lee J, Nyugen A, Yoneda KY, Lam KS, Li T. High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancer. Journal of Hematology & Oncology. 12: 56. PMID 31182116 DOI: 10.1186/s13045-019-0740-7  0.84
2019 Liang X, Junaid M, Wang Z, Li T, Xu N. Spatiotemporal distribution, source apportionment and ecological risk assessment of PBDEs and PAHs in the Guanlan River from rapidly urbanizing areas of Shenzhen, China. Environmental Pollution (Barking, Essex : 1987). 250: 695-707. PMID 31035152 DOI: 10.1016/j.envpol.2019.04.107  0.72
2019 Gong J, Gregg JP, Ma W, Yoneda K, Moore EH, Daly ME, Zhang Y, Williams MJ, Li T. Squamous Cell Transformation of Primary Lung Adenocarcinoma in a Patient With EML4-ALK Fusion Variant 5 Refractory to ALK Inhibitors. Journal of the National Comprehensive Cancer Network : Jnccn. 17: 297-301. PMID 30959466 DOI: 10.6004/jnccn.2019.7291  0.84
2019 Shi Y, Zhang J, Tian X, Wu X, Li T, Lu C, Shen Y. Isolation of 11,12- seco-Rifamycin W Derivatives Reveals a Cleavage Pattern of the Rifamycin Ansa Chain. Organic Letters. PMID 30714736 DOI: 10.1021/acs.orglett.8b03792  0.52
2018 Li T, Ma W, Tian EC. Ensartinib (X-396): what does it add for patients with ALK-rearranged NSCLC. Chinese Clinical Oncology. PMID 30525756 DOI: 10.21037/cco.2018.10.12  0.84
2018 Li Q, Ma W, Li T. Sortilin as a new membrane inhibitor of EGFR trafficking for overcoming resistance to EGFR inhibitors in non-small cell lung cancer. Journal of Thoracic Disease. 10: S3186-S3191. PMID 30430029 DOI: 10.21037/jtd.2018.08.25  0.84
2018 Li T, Zhang D, Oo TN, San MM, Mon AM, Hein PP, Wang Y, Lu C, Yang X. Investigation on the Antibacterial and Anti-T3SS Activity of Traditional Myanmar Medicinal Plants. Evidence-Based Complementary and Alternative Medicine : Ecam. 2018: 2812908. PMID 30402120 DOI: 10.1155/2018/2812908  0.52
2018 Zhou C, Yuan Z, Ma W, Qi L, Mahavongtrakul A, Li Y, Li H, Gong J, Fan RR, Li J, Molmen M, Clark TA, Pavlick D, Frampton GM, Forcier B, ... ... Li T, et al. Clinical utility of tumor genomic profiling in patients with high plasma circulating tumor DNA burden or metabolically active tumors. Journal of Hematology & Oncology. 11: 129. PMID 30400986 DOI: 10.1186/s13045-018-0671-8  0.84
2018 Schrock AB, Welsh A, Chung JH, Pavlick D, Bernicker EH, Creelan BC, Forcier B, Ross JS, Stephens PJ, Ali SM, Dagogo-Jack I, Shaw AT, Li T, Ou SI, Miller VA. Hybrid capture-based genomic profiling of circulating tumor DNA from patients with advanced non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 30368012 DOI: 10.1016/j.jtho.2018.10.008  0.4
2018 Guo X, Wang Y, Zhai Z, Huang T, Zhao D, Peng X, Feng C, Xiao Y, Li T. Transcriptomic analysis of light-dependent anthocyanin accumulation in bicolored cherry fruits. Plant Physiology and Biochemistry : Ppb. PMID 30131207 DOI: 10.1016/j.plaphy.2018.08.016  0.52
2018 Yang J, Siri JG, Remais JV, Cheng Q, Zhang H, Chan KKY, Sun Z, Zhao Y, Cong N, Li X, Zhang W, Bai Y, Bi J, Cai W, Chan EYY, ... ... Li T, et al. The Tsinghua-Lancet Commission on Healthy Cities in China: unlocking the power of cities for a healthy China. Lancet (London, England). PMID 29678340 DOI: 10.1016/S0140-6736(18)30486-0  0.72
2018 Sun X, Qi H, Zhang X, Li L, Zhang J, Zeng Q, Laszlo GS, Wei B, Li T, Jiang J, Mogilner A, Fu X, Zhao M. Src activation decouples cell division orientation from cell geometry in mammalian cells. Biomaterials. 170: 82-94. PMID 29653289 DOI: 10.1016/j.biomaterials.2018.03.052  0.52
2018 Liu W, Wu T, Li Q, Zhang X, Xu X, Li T, Han Z, Wang Y. An ethylene response factor (MxERF4) functions as a repressor of Fe acquisition in Malus xiaojinensis. Scientific Reports. 8: 1068. PMID 29348657 DOI: 10.1038/s41598-018-19518-4  0.52
2017 Dyer BA, Nguyen KNB, Shukla RP, Li T, Daly ME. Durable Local Control Following Concurrent Hypofractionated Chemoradiation for a Massive Inflammatory Breast Cancer Chest Wall Recurrence. Cureus. 9: e1379. PMID 28775919 DOI: 10.7759/cureus.1379  0.36
2017 Guo X, Ma Z, Zhang Z, Cheng L, Zhang X, Li T. Small RNA-Sequencing Links Physiological Changes and RdDM Process to Vegetative-to-Floral Transition in Apple. Frontiers in Plant Science. 8: 873. PMID 28611800 DOI: 10.3389/fpls.2017.00873  0.52
2017 Zhang Z, Guo X, Ge C, Ma Z, Jiang M, Li T, Koiwa H, Yang SW, Zhang X. KETCH1 imports HYL1 to nucleus for miRNA biogenesis in Arabidopsis. Proceedings of the National Academy of Sciences of the United States of America. PMID 28348234 DOI: 10.1073/pnas.1619755114  0.52
2017 Li H, Ma W, Yoneda KY, Moore EH, Zhang Y, Pu LL, Frampton GM, Molmen M, Stephens PJ, Li T. Severe nivolumab-induced pneumonitis preceding durable clinical remission in a patient with refractory, metastatic lung squamous cell cancer: a case report. Journal of Hematology & Oncology. 10: 64. PMID 28245875 DOI: 10.1186/s13045-017-0433-z  0.84
2017 Shen X, Guo X, Guo X, Zhao D, Zhao W, Chen J, Li T. PacMYBA, a sweet cherry R2R3-MYB transcription factor, is a positive regulator of salt stress tolerance and pathogen resistance. Plant Physiology and Biochemistry : Ppb. 112: 302-311. PMID 28126679 DOI: 10.1016/j.plaphy.2017.01.015  0.52
2016 Liao X, Guo X, Wang Q, Wang Y, Zhao D, Yao L, Wang S, Liu G, Li T. Overexpression of MsDREB6.2 results in cytokinin-deficient developmental phenotypes and enhances drought tolerance in transgenic apple plants. The Plant Journal : For Cell and Molecular Biology. PMID 27754576 DOI: 10.1111/tpj.13401  0.52
2016 Pan A, Zhang H, Li Y, Lin TY, Wang F, Lee J, Cheng M, Dall'Era M, Li T, deVere White R, Pan CX, Lam KS. Disulfide-crosslinked nanomicelles confer cancer-specific drug delivery and improve efficacy of paclitaxel in bladder cancer. Nanotechnology. 27: 425103. PMID 27640312 DOI: 10.1088/0957-4484/27/42/425103  0.4
2016 Li T, Bai F, Han P, Zhang Y. Non-Point Source Pollutant Load Variation in Rapid Urbanization Areas by Remote Sensing, Gis and the L-THIA Model: A Case in Bao'an District, Shenzhen, China. Environmental Management. PMID 27617329 DOI: 10.1007/s00267-016-0743-x  0.44
2016 Lin TY, Li Y, Liu Q, Chen JL, Zhang H, Lac D, Zhang H, Ferrara KW, Wachsmann-Hogiu S, Li T, Airhart S, deVere White R, Lam KS, Pan CX. Novel theranostic nanoporphyrins for photodynamic diagnosis and trimodal therapy for bladder cancer. Biomaterials. 104: 339-351. PMID 27479049 DOI: 10.1016/j.biomaterials.2016.07.026  0.4
2016 Yue Y, Ni J, Ciais P, Piao S, Wang T, Huang M, Borthwick AG, Li T, Wang Y, Chappell A, Van Oost K. Lateral transport of soil carbon and land-atmosphere CO2 flux induced by water erosion in China. Proceedings of the National Academy of Sciences of the United States of America. PMID 27247397 DOI: 10.1073/pnas.1523358113  0.44
2016 Ma W, Gilligan BM, Yuan J, Li T. Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy. Journal of Hematology & Oncology. 9: 47. PMID 27234522 DOI: 10.1186/s13045-016-0277-y  0.84
2015 Wang WP, Ho PY, Chen QX, Addepalli B, Limbach PA, Li MM, Wu WJ, Jilek JL, Qiu JX, Zhang HJ, Li T, Wun T, White RD, Lam KS, Yu AM. Bioengineering Novel Chimeric microRNA-34a for Prodrug Cancer Therapy: High-Yield Expression and Purification, and Structural and Functional Characterization. The Journal of Pharmacology and Experimental Therapeutics. 354: 131-41. PMID 26022002 DOI: 10.1124/jpet.115.225631  0.4
2015 Gandara DR, Mack PC, Bult C, Li T, Lara PN, Riess JW, Astrow SH, Gandour-Edwards R, Cooke DT, Yoneda KY, Moore EH, Pan CX, Burich RA, David EA, Keck JG, et al. Bridging tumor genomics to patient outcomes through an integrated patient-derived xenograft platform. Clinical Lung Cancer. 16: 165-72. PMID 25838158 DOI: 10.1016/j.cllc.2015.03.001  0.4
2015 Zhou Y, Honda M, Zhu H, Zhang Z, Guo X, Li T, Li Z, Peng X, Nakajima K, Duan L, Zhang X. Spatiotemporal sequestration of miR165/166 by Arabidopsis Argonaute10 promotes shoot apical meristem maintenance. Cell Reports. 10: 1819-27. PMID 25801022 DOI: 10.1016/j.celrep.2015.02.047  0.52
2015 Tomlinson BK, Thomson JA, Bomalaski JS, Diaz M, Akande T, Mahaffey N, Li T, Dutia MP, Kelly K, Gong IY, Semrad T, Gandara DR, Pan CX, Lara PN. Phase I Trial of Arginine Deprivation Therapy with ADI-PEG 20 Plus Docetaxel in Patients with Advanced Malignant Solid Tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 2480-6. PMID 25739672 DOI: 10.1158/1078-0432.CCR-14-2610  0.4
2014 Shen X, Zhao K, Liu L, Zhang K, Yuan H, Liao X, Wang Q, Guo X, Li F, Li T. A role for PacMYBA in ABA-regulated anthocyanin biosynthesis in red-colored sweet cherry cv. Hong Deng (Prunus avium L.). Plant & Cell Physiology. 55: 862-80. PMID 24443499 DOI: 10.1093/pcp/pcu013  0.52
2014 Li T, Maus MK, Desai SJ, Beckett LA, Stephens C, Huang E, Hsiang J, Zeger G, Danenberg KD, Astrow SH, Gandara DR. Large-scale screening and molecular characterization of EML4-ALK fusion variants in archival non-small-cell lung cancer tumor specimens using quantitative reverse transcription polymerase chain reaction assays. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: 18-25. PMID 24346090 DOI: 10.1097/JTO.0000000000000030  0.4
2014 Gandara DR, Li T, Lara PN, Kelly K, Riess JW, Redman MW, Mack PC. Acquired resistance to targeted therapies against oncogene-driven non-small-cell lung cancer: approach to subtyping progressive disease and clinical implications. Clinical Lung Cancer. 15: 1-6. PMID 24176733 DOI: 10.1016/j.cllc.2013.10.001  0.4
2013 Hong SY, Shih YP, Li T, Carraway KL, Lo SH. CTEN prolongs signaling by EGFR through reducing its ligand-induced degradation. Cancer Research. 73: 5266-76. PMID 23774213 DOI: 10.1158/0008-5472.CAN-12-4441  0.4
2013 Zhao K, Shen X, Yuan H, Liu Y, Liao X, Wang Q, Liu L, Li F, Li T. Isolation and characterization of dehydration-responsive element-binding factor 2C (MsDREB2C) from Malus sieversii Roem. Plant & Cell Physiology. 54: 1415-30. PMID 23757363 DOI: 10.1093/pcp/pct087  0.48
2013 Yuan H, Zhao K, Lei H, Shen X, Liu Y, Liao X, Li T. Genome-wide analysis of the GH3 family in apple (Malus × domestica). Bmc Genomics. 14: 297. PMID 23638690 DOI: 10.1186/1471-2164-14-297  0.48
2013 Maus MK, Mack PC, Astrow SH, Stephens CL, Zeger GD, Grimminger PP, Hsiang JH, Huang E, Li T, Lara PN, Danenberg KD, Gandara DR. Histology-related associations of ERCC1, RRM1, and TS biomarkers in patients with non-small-cell lung cancer: implications for therapy. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 8: 582-6. PMID 23470290 DOI: 10.1097/JTO.0b013e318287c3c5  0.4
2012 Gandara DR, Li T, Lara PN, Mack PC, Kelly K, Miyamoto S, Goodwin N, Beckett L, Redman MW. Algorithm for codevelopment of new drug-predictive biomarker combinations: accounting for inter- and intrapatient tumor heterogeneity. Clinical Lung Cancer. 13: 321-5. PMID 22677432 DOI: 10.1016/j.cllc.2012.05.004  0.4
2012 Li T, Guo M, Gradishar WJ, Sparano JA, Perez EA, Wang M, Sledge GW. A phase II trial of capecitabine in combination with the farnesyltransferase inhibitor tipifarnib in patients with anthracycline-treated and taxane-resistant metastatic breast cancer: an Eastern Cooperative Oncology Group Study (E1103). Breast Cancer Research and Treatment. 134: 345-52. PMID 22547107 DOI: 10.1007/s10549-012-2071-z  0.32
2012 Li T, Christensen SD, Frankel PH, Margolin KA, Agarwala SS, Luu T, Mack PC, Lara PN, Gandara DR. A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trial. Investigational New Drugs. 30: 741-8. PMID 20967484 DOI: 10.1007/s10637-010-9562-8  0.4
2011 Liu Y, Liu X, Zhong F, Tian R, Zhang K, Zhang X, Li T. Comparative study of phenolic compounds and antioxidant activity in different species of cherries. Journal of Food Science. 76: C633-8. PMID 22417346 DOI: 10.1111/j.1750-3841.2011.02150.x  0.52
2011 Sangha R, Davies AM, Lara PN, Mack PC, Beckett LA, Hesketh PJ, Lau D, Li T, Perkins N, Gandara DR. Intercalated erlotinib-docetaxel dosing schedules designed to achieve pharmacodynamic separation: results of a phase I/II trial. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 6: 2112-9. PMID 21892109 DOI: 10.1097/JTO.0b013e31822ae061  0.4
2010 Li T. Patient selection in non-small cell lung cancer: Histologic versus molecular subtypes? Journal of Thoracic Disease. 2: 189-91. PMID 22263043 DOI: 10.3978/j.issn.2072-1439.2010.11.9  0.4
2010 Chen H, Zhou S, Li T. Impact of extracellular polymeric substances on the settlement ability of aerobic granular sludge. Environmental Technology. 31: 1601-12. PMID 21275256 DOI: 10.1080/09593330.2010.482146  0.32
2010 Zhao H, Zhao B, Yang W, Li T. Effects of Ca2+ and Mg2+ on defluoridation in the electrocoagulation process. Environmental Science & Technology. 44: 9112-6. PMID 20977240 DOI: 10.1021/es102540t  0.36
2010 Gandara DR, Grimminger P, Mack PC, Lara PN, Li T, Danenberg PV, Danenberg KD. Association of epidermal growth factor receptor activating mutations with low ERCC1 gene expression in non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 5: 1933-8. PMID 20975603 DOI: 10.1097/JTO.0b013e3181fd418d  0.4
2009 Pohl NM, Tong C, Fang W, Bi X, Li T, Yang W. Transcriptional regulation and biological functions of selenium-binding protein 1 in colorectal cancer in vitro and in nude mouse xenografts. Plos One. 4: e7774. PMID 19924303 DOI: 10.1371/journal.pone.0007774  0.4
2009 Sparano JA, Moulder S, Kazi A, Coppola D, Negassa A, Vahdat L, Li T, Pellegrino C, Fineberg S, Munster P, Malafa M, Lee D, Hoschander S, Hopkins U, Hershman D, et al. Phase II trial of tipifarnib plus neoadjuvant doxorubicin-cyclophosphamide in patients with clinical stage IIB-IIIC breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 2942-8. PMID 19351752 DOI: 10.1158/1078-0432.CCR-08-2658  0.32
2008 Li T, Sparano JA. Farnesyl transferase inhibitors. Cancer Investigation. 26: 653-61. PMID 18665473 DOI: 10.1080/07357900801971016  0.32
2008 Li T, Yang W, Li M, Byun DS, Tong C, Nasser S, Zhuang M, Arango D, Mariadason JM, Augenlicht LH. Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer. Molecular Nutrition & Food Research. 52: 1289-99. PMID 18435490 DOI: 10.1002/mnfr.200700331  0.4
2006 Sparano JA, Moulder S, Kazi A, Vahdat L, Li T, Pellegrino C, Munster P, Malafa M, Lee D, Hoschander S, Hopkins U, Hershman D, Wright JJ, Sebti SM. Targeted inhibition of farnesyltransferase in locally advanced breast cancer: a phase I and II trial of tipifarnib plus dose-dense doxorubicin and cyclophosphamide. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 3013-8. PMID 16769985 DOI: 10.1200/JCO.2005.04.9114  0.32
2006 Li T, Sotgia F, Vuolo MA, Li M, Yang WC, Pestell RG, Sparano JA, Lisanti MP. Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status. The American Journal of Pathology. 168: 1998-2013. PMID 16723714  0.32
2004 Sparano JA, Lee S, Chen MG, Nazeer T, Einzig A, Ambinder RF, Henry DH, Manalo J, Li T, Von Roenn JH. Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Trial (E1494). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 1491-500. PMID 15084622 DOI: 10.1200/JCO.2004.08.195  0.4
2003 Li T, Sparano JA. Inhibiting Ras signaling in the therapy of breast cancer. Clinical Breast Cancer. 3: 405-16; discussion 4. PMID 12636885 DOI: 10.3816/CBC.2003.n.005  0.32
Low-probability matches
2017 Li T, Ding Y. Spatial disparity dynamics of ecosystem service values and GDP in Shaanxi Province, China in the last 30 years. Plos One. 12: e0174562. PMID 28358918 DOI: 10.1371/journal.pone.0174562  0.28
2012 Lei J, Niu H, Li T, Huang W. A novel β-glucosidase from Aspergillus fumigates releases diosgenin from spirostanosides of Dioscorea zingiberensis C. H. Wright (DZW). World Journal of Microbiology & Biotechnology. 28: 1309-14. PMID 22805852 DOI: 10.1007/s11274-011-0907-z  0.28
2011 Perez-Soler R, Zou Y, Li T, Ling YH. The phosphatase inhibitor menadione (vitamin K3) protects cells from EGFR inhibition by erlotinib and cetuximab. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 6766-77. PMID 21914790 DOI: 10.1158/1078-0432.CCR-11-0545  0.28
2010 Ni J, Sun L, Li T, Huang Z, Borthwick AG. Assessment of flooding impacts in terms of sustainability in Mainland China. Journal of Environmental Management. 91: 1930-42. PMID 20627544 DOI: 10.1016/j.jenvman.2010.02.010  0.28
2019 Reckamp KL, Frankel PH, Ruel N, Mack PC, Gitlitz BJ, Li T, Koczywas M, Gadgeel SM, Cristea MC, Belani CP, Newman EM, Gandara DR, Lara PN. Phase II Trial of Cabozantinib Plus Erlotinib in Patients With Advanced Epidermal Growth Factor Receptor ()-Mutant Non-small Cell Lung Cancer With Progressive Disease on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy: A California Cancer Consortium Phase II Trial (NCI 9303). Frontiers in Oncology. 9: 132. PMID 30915273 DOI: 10.3389/fonc.2019.00132  0.2
2016 Gandara DR, Riess JW, Kelly K, Li T, Mack PC, Lara PN. Evolution and Increasing Complexity of the Therapeutic Landscape in Advanced Non-Small-cell Lung Cancer. Clinical Lung Cancer. PMID 28082049 DOI: 10.1016/j.cllc.2016.12.011  0.2
2016 Li T, Piperdi B, Walsh WV, Kim M, Beckett LA, Gucalp R, Haigentz M, Bathini VG, Wen H, Zhou K, Pasquinelli PB, Gajavelli S, Sreedhara M, Xie X, Lara PN, et al. Randomized Phase 2 Trial of Pharmacodynamic Separation of Pemetrexed and Intercalated Erlotinib Versus Pemetrexed Alone for Advanced Nonsquamous, Non-small-cell Lung Cancer. Clinical Lung Cancer. PMID 27919627 DOI: 10.1016/j.cllc.2016.10.003  0.2
2015 Lara PN, Longmate J, Mack PC, Kelly K, Socinski MA, Salgia R, Gitlitz B, Li T, Koczywas M, Reckamp KL, Gandara DR. Phase II Study of the AKT inhibitor MK-2206 plus Erlotinib in Patients with Advanced Non-Small Cell Lung Cancer who Previously Progressed on Erlotinib. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26106072 DOI: 10.1158/1078-0432.CCR-14-3281  0.2
2013 Perez-Soler R, Zou Y, Li T, Ling YH. Retraction: The phosphatase inhibitor menadione (vitamin K3) protects cells from EGFR inhibition by erlotinib and cetuximab. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 4901. PMID 24003062 DOI: 10.1158/1078-0432.CCR-13-1912  0.2
2013 Li T, Kung HJ, Mack PC, Gandara DR. Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 1039-49. PMID 23401433 DOI: 10.1200/JCO.2012.45.3753  0.2
2010 Gandara DR, Mack PC, Li T, Lara PN, Herbst RS. [Evolving treatment algorithms for advanced non-small-cell lung cancer: 2009 looking toward 2012]. Zhongguo Fei Ai Za Zhi = Chinese Journal of Lung Cancer. 13: 238-41. PMID 20681067 DOI: 10.3779/j.issn.1009-3419.2010.03.16  0.2
2010 Li T, Lara PN, Mack PC, Perez-Soler R, Gandara DR. Intercalation of erlotinib and pemetrexed in the treatment of non-small cell lung cancer. Current Drug Targets. 11: 85-94. PMID 19839922  0.2
2009 Gandara DR, Mack PC, Li T, Lara PN, Herbst RS. Evolving treatment algorithms for advanced non-small-cell lung cancer: 2009 looking toward 2012. Clinical Lung Cancer. 10: 392-4. PMID 19900855 DOI: 10.3816/CLC.2009.n.074  0.2
2007 Li T, Ling YH, Goldman ID, Perez-Soler R. Schedule-dependent cytotoxic synergism of pemetrexed and erlotinib in human non-small cell lung cancer cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 3413-22. PMID 17545550 DOI: 10.1158/1078-0432.CCR-06-2923  0.16
2009 Ling YH, Li T, Perez-Soler R, Haigentz M. Activation of ER stress and inhibition of EGFR N-glycosylation by tunicamycin enhances susceptibility of human non-small cell lung cancer cells to erlotinib. Cancer Chemotherapy and Pharmacology. 64: 539-48. PMID 19130057 DOI: 10.1007/s00280-008-0902-8  0.12
2008 Li T, Ling YH, Perez-Soler R. Tumor dependence on the EGFR signaling pathway expressed by the p-EGFR:p-AKT ratio predicts erlotinib sensitivity in human non-small cell lung cancer (NSCLC) cells expressing wild-type EGFR gene. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 3: 643-7. PMID 18520805 DOI: 10.1097/JTO.0b013e3181753b24  0.12
2016 Li T, LoRusso P, Maitland ML, Ou SH, Bahceci E, Ball HA, Park JW, Yuen G, Tolcher A. First-in-human, open-label dose-escalation and dose-expansion study of the safety, pharmacokinetics, and antitumor effects of an oral ALK inhibitor ASP3026 in patients with advanced solid tumors. Journal of Hematology & Oncology. 9: 23. PMID 26966027 DOI: 10.1186/s13045-016-0254-5  0.08
2019 Al-Obeidi E, Li T, Kelly K. Durable Responses to Afatinib as First-line Therapy for HER2-mutated Metastatic Non-small-cell Lung Cancer. Clinical Lung Cancer. PMID 31649001 DOI: 10.1016/j.cllc.2019.09.006  0.04
2010 Li T, Ho L, Piperdi B, Elrafei T, Camacho FJ, Rigas JR, Perez-Soler R, Gucalp R. Phase II study of the proteasome inhibitor bortezomib (PS-341, Velcade) in chemotherapy-naïve patients with advanced stage non-small cell lung cancer (NSCLC). Lung Cancer (Amsterdam, Netherlands). 68: 89-93. PMID 19524318 DOI: 10.1016/j.lungcan.2009.05.009  0.04
2007 Ling YH, Li T, Yuan Z, Haigentz M, Weber TK, Perez-Soler R. Erlotinib, an effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 up-regulation and nuclear translocation in association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines. Molecular Pharmacology. 72: 248-58. PMID 17456787 DOI: 10.1124/mol.107.034827  0.04
2019 Rotow JK, Gui P, Wu W, Raymond VM, Lanman RB, Kaye FJ, Peled N, Fece de la Cruz F, Nadres B, Corcoran RB, Yeh I, Bastian BC, Starostik P, Newsom K, Olivas V, ... ... Li T, et al. Co-occurring alterations in the RAS-MAPK pathway limit response to MET inhibitor treatment in MET exon 14 skipping mutation-positive lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31548343 DOI: 10.1158/1078-0432.CCR-19-1667  0.01
2018 Liu Y, Wang H, Song R, Chen J, Li T, Li Y, Du L, Shen Y. Targeted Discovery and Combinatorial Biosynthesis of Polycyclic Tetramate Macrolactam Combamides A-E. Organic Letters. PMID 29792712 DOI: 10.1021/acs.orglett.8b01285  0.52
2017 Shen X, Guo X, Zhao D, Zhang Q, Jiang Y, Wang Y, Peng X, Wei Y, Zhai Z, Zhao W, Li T. Cloning and expression profiling of the PacSnRK2 and PacPP2C gene families during fruit development, ABA treatment, and dehydration stress in sweet cherry. Plant Physiology and Biochemistry : Ppb. 119: 275-285. PMID 28926798 DOI: 10.1016/j.plaphy.2017.08.025  0.52
2016 Xiao W, Li T, Bononi FC, Lac D, Kekessie IA, Liu Y, Sanchez E, Mazloom A, Ma AH, Lin J, Tran J, Yang K, Lam KS, Liu R. Discovery and characterization of a high-affinity and high-specificity peptide ligand LXY30 for in vivo targeting of α3 integrin-expressing human tumors. Ejnmmi Research. 6: 18. PMID 26922417 DOI: 10.1186/s13550-016-0165-z  0.44
2015 Zhang X, An L, Nguyen TH, Liang H, Wang R, Liu X, Li T, Qi Y, Yu F. The Cloning and Functional Characterization of Peach CONSTANS and FLOWERING LOCUS T Homologous Genes PpCO and PpFT. Plos One. 10: e0124108. PMID 25905637 DOI: 10.1371/journal.pone.0124108  0.52
2009 Li T, Perez-Soler R. Skin toxicities associated with epidermal growth factor receptor inhibitors. Targeted Oncology. 4: 107-19. PMID 19452131 DOI: 10.1007/s11523-009-0114-0  0.01
Hide low-probability matches.